![](https://cdn.sanity.io/images/0vv8moc6/ajmc/e7fdf62a3eba5b90514d56dd75262e68f0ccabac-5760x3840.jpg?fit=crop&auto=format)
Study: Breast Cancer Immunotherapy Trials Make Modest Clinical Impact
Despite the numerous breast cancer immunotherapy trials conducted, they have only had a modest clinical impact, according to a review published in JAMA Network Open.1 Historically, breast cancer was not considered an immunogenic cancer.2 However, past …